Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03807648 · ClinicalTrials.gov registry record
I USE LR in the ED
A clinical trial of Kidney Injury, sponsored by Intermountain Health Care.
- Completed
- Registry status
- 200,000
- Enrollment target
- 1
- Study location
NCT03807648: Completed study of Kidney Injury, sponsored by Intermountain Health Care.
NCT03807648 is a study of Kidney Injury that has completed, run by Intermountain Health Care. The registered enrollment target is 200,000 participants, above the 307-participant average among 9 other Kidney Injury trials with a reported enrollment target (65047% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03807648, a study of Kidney Injury, has completed, sponsored by Intermountain Health Care.
- COMPLETED
- Registry status
- 200,000 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
Primary Outcome
death from any cause, new renal replacement therapy or persistent renal dysfunction
Conditions Studied
Interventions
- OTHER Data Inclusion
Study Locations (1)
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200,000 participants |
| Start Date | 2018-12-20 |
| Est. Completion | 2020-01-31 |
What the finished NCT03807648 record still lists
NCT03807648 is an observational study that tracks outcomes without assigning an intervention. Its 200,000 participants enrollment target places it among the larger protocols in the corpus, above the 307-participant average among 9 other Kidney Injury trials with a reported enrollment target (65047% higher).
The record links to 1 condition, with Kidney Injury appearing as the primary indexed condition, and to 1 intervention - of which Data Inclusion is the first listed.
NCT03807648 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT03807648 about?
NCT03807648 is a clinical study titled "I USE LR in the ED". To study the difference in mortality and major adverse kidney events during and after treatment in the emergency department with intravenous fluids per standard of care at 30 days before and after the system-wide implementation.
What is the current status of trial NCT03807648?
This trial is currently completed. The enrollment target is 200,000 participants. The study started on 2018-12-20. Estimated completion is 2020-01-31.
What conditions does trial NCT03807648 study?
This clinical trial studies the following conditions: Kidney Injury.
What interventions are being tested in trial NCT03807648?
The interventions under investigation include: Data Inclusion (OTHER).
Who is sponsoring clinical trial NCT03807648?
This trial is sponsored by Intermountain Health Care, which has 85 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03807648 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03807648's enrollment target sits among peer trials
200,000 1st of 9 higher than 9 of 9 other Kidney Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Kidney Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
SGC Stimulation, Perioperative Vascular Reactivity, and Organ Injury in Cardiac Surgery
RECRUITING · Phase 4
-
Pediatric Hypertension and the Renin-Angiotensin SystEm (PHRASE)
RECRUITING
-
KIDney Injury in Times of COVID-19 (KIDCOV)
RECRUITING
-
Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)
ACTIVE NOT RECRUITING · NA
-
Renal Considerations in the Heat Stress Recommendations (Aim2)
COMPLETED · NA
-
Evaluating Fluid Strategies in Thoracic Surgery Patients Utilizing a Goal Directed Approach
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT06917339 · 156,000 participants
Retrospective Analyses of TrakStar Database
- NCT06232551 · 152,000 participants · NA
Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI